Convalescent Plasma for COVID-19 Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

April 30, 2021

Conditions
COVID 19
Interventions
BIOLOGICAL

Convalescent COVID 19 Plasma

A total of 500 ml of convalescent COVID 19 plasma will be transfused intravenously per subject

Trial Locations (1)

10000

Vinmec Research Institute of Stem cell and Gene Technology, Hanoi

All Listed Sponsors
collaborator

National Institute of Hygiene and Epidemiology, Vietnam

OTHER

collaborator

National Hospital for Tropical Diseases, Hanoi, Vietnam

OTHER_GOV

collaborator

National Institute of Hematology and Blood Transfusion, Vietnam

OTHER

lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT04516954 - Convalescent Plasma for COVID-19 Patients | Biotech Hunter | Biotech Hunter